Educational App for Sleep in Bone Marrow Transplant Patients

This study is looking at whether an app-based educational program can help adults who are having an allogeneic hematopoietic stem cell transplant (alloHSCT), also known as a bone marrow transplant, manage their sleep. The program, called "The Sleep Adventure," aims to teach you about sleep and recovery in an easy-to-understand way. We want to see if this educational app works better than standard care. You can join if you are 18 or older and planning to have an alloHSCT. The main goal is to measure your sleep throughout the study, from two weeks before your transplant until 100 days after. The current recruitment status is unclear, but the study plans to enroll 60 patients.

Study design
This is a randomized, open-label study, meaning participants are randomly assigned to a group and everyone knows which treatment they are receiving. It's a pilot study aiming for 60 participants.
What's involved
Screening for eligibility will begin once you are identified as transplant eligible. You will then be contacted by a study investigator to discuss the study. If you join, you will be randomized to either the educational intervention or standard care.
Compensation
Not stated in the trial record.
Follow-up
Sleep will be measured continuously from 2 weeks prior to transplant until 100 days after transplant.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06590285

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

Recruiting
NAAges 18+InterventionalSupportive care
Scripps Health
~60 participants
Updated 2026-04-09 on ClinicalTrials.gov
What's tested:App-based Educational Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Objective Sleep Measurement
Measured over Continuous measurement throughout the study duration (from 2 weeks prior to alloHSCT to 100 days post-alloHSCT)
GVHD
Bone Marrow Transplant Complications
1 sites across 1 states
California1
  • Jake New, MD, PhD · PRINCIPAL_INVESTIGATOR · Scripps Clinic

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Male or female patients aged 18 or older at the time of study informed consent.
Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible.
Patients have access to digital device capable of downloading study app
Patients able to read study documents and able to complete informed consent within the study app

Exclusion

Failed prior alloHSCT within the past 6 months
  • Objective Sleep MeasurementContinuous measurement throughout the study duration (from 2 weeks prior to alloHSCT to 100 days post-alloHSCT)

    A wearable device will continuously measure objective sleep quality. The outcome will be reported as the average sleep duration (in minutes per day) over the study period. Data will be aggregated for the entire duration of the study.